Anaclim strives to recruit ethnically balanced populations of patients that are representative of the disease being studied, and perhaps more importantly, of the future users of the medical treatments being developed.

Minorities are significantly under-represented in clinical research. They are under-represented even in those therapeutic areas where ethnic minorities are disproportionatley affected:

  • Diabetes
  • Cardiovascular disease (CHF, AMI)
  • Hypertension
  • Stroke
  • AIDS
  • Certain cancers

Evelyn B, Toigo T, Banks D, et al: Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. J Nat'l Med Assoc. 2001 Dec;93 (12 Suppl):18S-24S.

Facts About Minorities

Accounted for 31.2% of total US population in the year 2000 Census

Account for 33-35% of total US population today

Will become 50% of total population in 2050

Hispanics and Asian will double from 2000 to 2050

Suffer a higher incidence of several diseases:

  • Type II Diabetes
  • Cardiovascular Disease (HTN, Stroke, CHF, AMI)
  • Certain Cancers (colon, breast, cervix, prostate, etc.)
  • AIDS
  • Neuropsychiatric illnesses